Eosinophils have been traditionally perceived as terminally differentiated cytotoxic effector
cells. Recent studies have profoundly altered this simplistic view of eosinophils and their …

Sixteen years ago, the Nomenclature Committee of the International Union of Pharmacology
approved a system for naming human seven-transmembrane (7TM) G protein-coupled …

Eosinophilic esophagitis (EoE) is a clinicopathologic condition of increasing recognition and
prevalence. In 2007, a consensus recommendation provided clinical and histopathologic …

Eosinophilic esophagitis (EoE) is a chronic immune-mediated disease of the esophagus
characterized clinically by symptoms related to esophageal dysfunction and histologically by …

Early in the 1990s, several case series described adults suffering from dysphagia and
children with refractory reflux symptoms, both accompanied by an eosinophil‐predominant …

BACKGROUND: Eosinophilic esophagitis (EE) is an emerging worldwide disease that
mimics gastroesophageal reflux disease. OBJECTIVE: Early studies have suggested that …

Sixteen years ago, the Nomenclature Committee of the International Union of Pharmacology
approved a system for naming human seven-transmembrane (7TM) G protein-coupled …

Interleukin‐5 is a Th2 homodimeric cytokine involved in the differentiation, maturation,
migration, development, survival, trafficking and effector function of blood and local tissue …

BACKGROUND: Recent research shows that both pediatric and adult patients with
eosinophilic esophagitis (EoE) experience esophageal remodeling marked by increased …

OBJECTIVES: Noninvasive biomarkers would be valuable for diagnosis and monitoring of
eosinophilic esophagitis (EoE). The aim of this study was to determine the utility of a panel of …